⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SILO News
Silo Pharma, Inc. Common Stock
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform
globenewswire.com
SILO
Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program
globenewswire.com
SILO
Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform
globenewswire.com
SILO
AMD
Form 8-K
sec.gov
SILO
Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
globenewswire.com
SILO
Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program
globenewswire.com
SILO
Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request
globenewswire.com
SILO
Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial
globenewswire.com
SILO
Form 8-K
sec.gov
SILO
Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
globenewswire.com
SILO